Clear cells in the atrioventricular valves of infants with severe human mucopolysaccharidosis (Hurler syndrome) are activated valvular interstitial cells

被引:11
作者
Braunlin, Elizabeth [1 ]
Tolar, Jakub [1 ]
Mackey-Bojack, Shannon [2 ]
Masinde, Tiwanda [3 ]
Krivit, William [1 ]
Schoen, Frederick J. [4 ,5 ]
机构
[1] Univ Minnesota Hosp Fairview, Dept Pediat, Minneapolis, MN 55455 USA
[2] Jesse E Edwards Registry Cardiovasc Dis, St Paul, MN USA
[3] NIEHS, Cellular & Mol Pathol Branch, Res Triangle Pk, NC 27709 USA
[4] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[5] Harvard Univ, Sch Med, Boston, MA USA
关键词
Mucopolysaccharide; Valve; Fibroblast; MITRAL-VALVES; HEART-VALVES; PROTEOGLYCANS; PATHOBIOLOGY;
D O I
10.1016/j.carpath.2010.06.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Severe mucopolysaccharidosis type I (Hurler syndrome) is an autosomal recessive lysosomal storage disease of childhood that results in accumulation of glycosaminoglycans within cardiac valves and consequent valve dysfunction. Valve thickening in mucopolysaccharidosis type 1 (Hurler syndrome) is due, in part, to the presence of glycosaminoglycan-laden cells (the so-called "clear" or "Hurler" cells) within the valve that remain largely unstudied with respect to identity, origin, and function. We hypothesized that the "clear" or "Hurler" cells within the atrioventricular valves from individuals with untreated mucopolysaccharidosis type I are activated valvular interstitial cells. Methods: We performed routine and immunohistochemical staining on atrioventricular valves from two infants with untreated severe mucopolysaccharidosis type I (Hurler syndrome) and compared them to atrioventricular valve tissue from two age-matched and gender-matched normal infants. Results: Despite the marked differences in their histological appearances, mucopolysaccharidosis type I valve cells have an immunohistochemical fingerprint identical to that of normal infant valvular interstitial cells. Both mucopolysaccharidosis type I valvular interstitial cells and normal infant valvular interstitial cells have the phenotype of activated myofibroblasts, as evidenced by positive staining for vimentin, smooth muscle actin, and metalloproteinase-9. However, the number of mucopolysaccharidosis type I valvular interstitial cells is significantly increased when compared to that of normal cells (P <.0031). Both mucopolysaccharidosis type I (Hurler syndrome) cells and normal valvular interstitial cells express CD34(+), a hematopoietic and capillary endothelial progenitor cell marker, suggesting a common response to activation. Conclusions: We conclude that "clear" or "Hurler" cells are valvular interstitial cells with the immunohistochemical phenotype of activated myofibroblasts and may be engaged, albeit ineffectively, in valve repair. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:315 / 321
页数:7
相关论文
共 19 条
[1]   Human semilunar cardiac valve remodeling by activated cells from fetus to adult - Implications for postnatal adaptation, pathology, and tissue engineering [J].
Aikawa, E ;
Whittaker, P ;
Farber, M ;
Mendelson, K ;
Padera, RF ;
Aikawa, M ;
Schoen, FJ .
CIRCULATION, 2006, 113 (10) :1344-1352
[2]   DEFECT IN HURLER AND SCHEIE SYNDROMES - DEFICIENCY OF ALPHA-IDURONIDASE [J].
BACH, G ;
WEISSMAN.B ;
FRIEDMAN, R ;
NEUFELD, EF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1972, 69 (08) :2048-&
[3]   Cordial connections: molecular ensembles and structures of adhering junctions connecting interstitial cells of cardiac valves in situ and in cell culture [J].
Barth, Mareike ;
Schumacher, Heiderose ;
Kuhn, Caecilia ;
Akhyari, Payam ;
Lichtenberg, Artur ;
Franke, Werner W. .
CELL AND TISSUE RESEARCH, 2009, 337 (01) :63-77
[4]   CD34+ fibrocytes in normal mitral valves and myxomatous mitral valve degeneration [J].
Barth, PJ ;
Köster, H ;
Moosdorf, R .
PATHOLOGY RESEARCH AND PRACTICE, 2005, 201 (04) :301-304
[5]   Usefulness of bone marrow transplantation in the Hurler syndrome [J].
Braunlin, EA ;
Stauffer, NR ;
Peters, CH ;
Bass, JL ;
Berry, JM ;
Hopwood, JJ ;
Krivit, W .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (07) :882-886
[6]   Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I [J].
Braunlin, Elizabeth A. ;
Berry, James M. ;
Whitley, Chester B. .
AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (03) :416-418
[7]   The cardiac fibroblast: Therapeutic target in myocardial remodeling and failure [J].
Brown, RD ;
Ambler, SK ;
Mitchell, MD ;
Long, CS .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2005, 45 :657-687
[8]   Accumulation of intracellular amyloid-β peptide (Aβ 1-40) in mucopolysaccharidosis brains [J].
Ginsberg, SD ;
Galvin, JE ;
Lee, VMY ;
Rorke, LB ;
Dickson, DW ;
Wolfe, JH ;
Jones, MZ ;
Trojanowski, JQ .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1999, 58 (08) :815-824
[9]   Glycosaminoglycans and proteoglycans in normal mitral valve leaflets and chordae: association with regions of tensile and compressive loading [J].
Grande-Allen, KJ ;
Calabro, A ;
Gupta, V ;
Wight, TN ;
Hascall, VC ;
Vesely, I .
GLYCOBIOLOGY, 2004, 14 (07) :621-633
[10]   Abundance and location of proteoglycans and hyaluronan within normal and myxomatous mitral valves [J].
Gupta, Vishal ;
Barzilla, Janet E. ;
Mendez, Joe S. ;
Stephens, Elizabeth H. ;
Lee, Elaine L. ;
Collard, C. David ;
Laucirica, Rodolfo ;
Weigel, Paul H. ;
Grande-Allen, Kathryn J. .
CARDIOVASCULAR PATHOLOGY, 2009, 18 (04) :191-197